Art Therapy for Pain Relief in Breast Cancer Patients
Can Art Therapy Improve Breast Cancer Patients' Perception of Persistent Post Treatment Pain and Functioning? A Mixed Methods Pilot Study
1 other identifier
observational
20
1 country
1
Brief Summary
Art therapy offers benefits and support for a range of psychological symptoms caused by cancer and its treatments, for example anxiety, stress, depression, sleeplessness, identity or end of life concerns. Persistent post treatment pain that adversely affects quality of life may be experienced by up to 50% of breast cancer patients. Factors such as depression, fear, anxiety or lack of sleep are shown to increase pain and suffering in people with cancer. A multitreatment approach treatment of cancer pain is therefore recommended. Art therapy offers an opportunity to communicate the experience of suffering in a non verbal mode and can be offered in addition to other treatment for pain. This pilot study proposes to explore the effect of art therapy on breast cancer patients' perception of pain, and its impact on daily functioning by offering four sessions of individual art therapy, spaced between one to three weeks apart.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 5, 2016
CompletedFirst Posted
Study publicly available on registry
February 11, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedMay 1, 2018
April 1, 2018
3.8 years
January 5, 2016
April 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patient showing change in Brief Pain Inventory pain interference score
The percentage of patients who will demonstrate a 2 point change in Brief Pain Inventory pain interference score from baseline to end of study.
From baseline to end of the study (approx six months)
Secondary Outcomes (1)
Percentage of patient showing change in Brief Pain Inventory pain severity score
From baseline to end of the study (approx six months)
Study Arms (1)
Breast Cancer Patients
This pilot study proposes to explore the effect of art therapy on breast cancer patients' perception of pain, and its impact on daily functioning by offering four sessions of individual art therapy, spaced between one to three weeks apart. The study will be open to breast cancer patients over the age of 18, who have been assessed by the Royal Marsden (RM) Pain Team, and who report having persistent post treatment pain of at least moderate intensity for the preceding two weeks despite having been optimally treated for their pain already, and who fulfil the inclusion criteria.
Interventions
Patients fulfilling the inclusion criteria will be made an appointment with the art therapist for the Initial Assessment session. They will be given the following Reflect Interview session Final interview session An analgesic use form will be given to the patient to take home to note their actual analgesic use At the end of each of these art therapy sessions, patients will be given a Brief Pain Inventory form (BPI) with a stamped addressed envelope. This is to be completed twenty four hours after the appointment and returned by post.
Eligibility Criteria
Patient with breast cancer as assessed by the RM pain team.
You may qualify if:
- reporting pain of longer than three months duration post chemotherapy, surgical or radiation treatment
- aged 18 years or older
- with more than two months predicted life expectancy
- who has English fluency
- who has capacity to consent
- wishing to access art therapy
- who is assessed by the pain team as stable on their current medication
You may not qualify if:
- who is less than three months post their chemotherapy or radiation treatment, or who receives new chemotherapy or radiation treatment during the study.
- who has had pain reduction surgery less than three months before the study, or receives it during the study period
- who has had any change in medication for pain control less than two weeks prior to the study, or during the study period
- who scores less than moderate pain (less than 4 on a scale of 1 -10) in a verbal self-reported measure of their worst pain felt, for the preceding two weeks before the study period
- who intends to access art therapy outside the sessions offered within the study, for the duration of the study
- who receives other psychological therapies from another practitioner during the study period
- who receives physiotherapy for problems related to their breast cancer treatment during the study period
- who receives massage or reflexology treatments from the complementary therapy team during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Royal Marsden NHS Foundation Trust
London, SW3 6JJ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clare Shaw, BSc,RD,PhD
Royal Marsden NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2016
First Posted
February 11, 2016
Study Start
June 1, 2015
Primary Completion
March 1, 2019
Study Completion
August 1, 2019
Last Updated
May 1, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share